Mental health problems increase amid Covid-19 pandemic, causing a catastrophic impact on patients and their family members. During this special period, it has become especially important to raise public awareness for mental health. The UN has urged governments around the world to take the mental health consequences seriously, and ensure widespread availability of mental health support. “Mental health services are an essential part of all government responses to Covid-19. They must be expanded and fully funded”, said the UN Secretary General Antonio Guterres.

 

Luye Pharma collaborated with partners from multiple countries to increase the accessibility of Seroquel® in emerging markets around the world including APAC and LATAM. The team of Luye Pharma has also launched a mental health awareness initiative “We Care About Mental Health” designed to raise awareness of the importance of mental health issues faced by society today, and intended to reach participants across multiple regions. Series of activities including online and offline lectures by key opinion leaders across the region, helping to educate the public and further raise awareness of matters related to mental illness.

 

 

The time to act is now “We Care About Mental Health".

 

• On May, Luye Pharma has entered into an exclusive promotion agreement with Moksha8 Brasil Distribuidora e Representação de Medicamentos Ltda. and Moksha8 Farmacéutica, S. de R.L. de C.V., two subsidiaries of Moksha8 Pharmaceuticals (Moksha8), granting exclusive promotion rights to Moksha8 in Brazil and Mexico, for Luye's  CNS drugs Seroquel® and Seroquel XR®.

 

• On Jun, Luye Pharma held a special signing ceremony as part of the “We Care About Mental Health” initiative, marking the start of three new strategic partnerships across APAC. As part of the initiative, Luye Pharma granted Alvogen Korea Co. Ltd. (Alvogen Korea), Zuellig Pharma Ltd. (Zuellig Pharma) and DKSH (Thailand) Ltd. (DKSH) exclusive distribution and marketing rights to Seroquel® and Seroquel XR® in their respective regions of South Korea, Hong Kong and Thailand. Following the signing, the parties came together to issue a call for action as part of the “We Care About Mental Health” initiative, raising awareness and supporting patients, physicians and health systems in overcoming the huge unmet needs. This is especially timely against the challenging backdrop of the COVID-19 pandemic.
   

 

Luye Pharma signs agreements with partners
(Upper left to right: Dr. Yehong Zhang, President of Luye Pharma (International); Justin Lee, Country Manager of Alvogen Korea;
Lower left to right: Andi Umbricht, Chief Executive of Zuellig Pharma Hong Kong & Macau; Bijay Singh, Global Head of Business Unit Healthcare of DKSH)
 

Luye Pharma and partners launch the “We Care About Mental Health” initiative
(Upper left to right: Andy Siow, APAC Regional Director of Luye Pharma (International); Justin Lee, Country Manager of Alvogen Korea;
Lower left to right: Andi Umbricht, Chief Executive of Zuellig Pharma Hong Kong & Macau;
John Clare, Vice President Healthcare of DKSH Thailand & Indochina)

 

“We have rolled out a complete deck of materials and implementation guides on We Care About Mental Health with all internal team members and our partners across the regions. The time to act is now, the team will follow through with partners to support the integration of the initiative into 2H implementation plan for each Seroquel country.

 

We Care About Mental Health initiative would not have been possible without the remarkable teamwork and fearsome effort from the TEAM. The swiftness, resourcefulness, originality, inspiration, the 'impossible is nothing attitude' and the undeniably fellowship in Luye Family! Special thanks go to Allen & Vivian, Brian & Cooper, Jun & Tina, Yehong & Paul and all Luye Team members that supported the 3 Zoom events." 

—— Andy Siow, APAC Regional Director of Luye Pharma (International)

 

Closely followed the Asia Pacific, Latin America team had launched a similar campaign “We Care About Mental Health” and achieved encouraging response and very positive results.

The campaign was organized via webinar, endorsed by the Mexican Psychiatry Association and led by its president, Dr. Bernardo Ng. More than 200 attendees participated the webinar and the link was shared through the Mx association.The first speaker approached his experience on how to cope with COVID-19 psychology effects and discussed about the risks of the Mental health Pandemic. More encouragingly, the second speaker approached a positive perspective of the life showing the good side of that issue.

 

 

 

“During the implementation of this initiative, Luye International team is well integrated. Maybe this team work initiative should be emphasized as well 'Together is better'.”

—Marcos de Paula，LATAM Commercial Manager of Luye Pharma (International)